Legal & General Group PLC Ani Pharmaceuticals Inc Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Legal & General Group PLC holds 48,425 shares of ANIP stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,425
Previous 45,840 5.64%
Holding current value
$3 Million
Previous $2.73 Million 2.12%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$53.35 - $61.74 $137,909 - $159,597
2,585 Added 5.64%
48,425 $2.68 Million
Q3 2024

Feb 28, 2025
SELL
$54.33 - $65.72 $201,238 - $243,426
-3,704 Reduced 7.65%
44,721 $2.67 Million
Q3 2024

Nov 14, 2024
BUY
$54.33 - $65.72 $93,827 - $113,498
1,727 Added 3.91%
45,840 $2.73 Million
Q2 2024

Aug 14, 2024
BUY
$58.53 - $68.82 $132,160 - $155,395
2,258 Added 5.39%
44,113 $2.81 Million
Q1 2024

May 14, 2024
BUY
$54.2 - $69.69 $10,840 - $13,938
200 Added 0.48%
41,855 $2.89 Million
Q4 2023

Feb 15, 2024
SELL
$48.72 - $65.43 $106,940 - $143,618
-2,195 Reduced 5.01%
41,655 $2.3 Million
Q3 2023

Nov 14, 2023
BUY
$50.28 - $64.61 $283,880 - $364,788
5,646 Added 14.78%
43,850 $2.55 Million
Q2 2023

Aug 14, 2023
BUY
$37.29 - $53.83 $331,209 - $478,118
8,882 Added 30.29%
38,204 $2.06 Million
Q1 2023

May 15, 2023
SELL
$37.61 - $45.72 $16,021 - $19,476
-426 Reduced 1.43%
29,322 $1.16 Million
Q4 2022

Feb 14, 2023
BUY
$31.9 - $41.95 $32,569 - $42,830
1,021 Added 3.55%
29,748 $1.2 Million
Q3 2022

Nov 14, 2022
SELL
$29.83 - $38.01 $45,371 - $57,813
-1,521 Reduced 5.03%
28,727 $923,000
Q2 2022

Aug 22, 2022
BUY
$23.09 - $33.46 $18,518 - $26,834
802 Added 2.72%
30,248 $897,000
Q1 2022

May 16, 2022
BUY
$26.91 - $47.15 $83,582 - $146,447
3,106 Added 11.79%
29,446 $828,000
Q4 2021

Feb 14, 2022
BUY
$32.97 - $56.85 $144,276 - $248,775
4,376 Added 19.92%
26,340 $1.21 Million
Q3 2021

Nov 15, 2021
BUY
$26.48 - $35.99 $39,614 - $53,841
1,496 Added 7.31%
21,964 $721,000
Q2 2021

Aug 12, 2021
SELL
$31.86 - $38.6 $195,652 - $237,042
-6,141 Reduced 23.08%
20,468 $716,000
Q1 2021

May 17, 2021
BUY
$28.4 - $36.14 $8,065 - $10,263
284 Added 1.08%
26,609 $963,000
Q4 2020

Feb 12, 2021
SELL
$23.69 - $31.47 $3,174 - $4,216
-134 Reduced 0.51%
26,325 $764,000
Q3 2020

Nov 13, 2020
BUY
$26.38 - $33.1 $17,753 - $22,276
673 Added 2.61%
26,459 $746,000
Q2 2020

Aug 14, 2020
BUY
$29.93 - $50.1 $65,157 - $109,067
2,177 Added 9.22%
25,786 $834,000
Q1 2020

May 14, 2020
SELL
$30.35 - $67.14 $1,092 - $2,417
-36 Reduced 0.15%
23,609 $961,000
Q4 2019

Feb 13, 2020
BUY
$55.65 - $79.83 $99,613 - $142,895
1,790 Added 8.19%
23,645 $1.46 Million
Q3 2019

Nov 13, 2019
BUY
$64.7 - $85.39 $127,588 - $168,389
1,972 Added 9.92%
21,855 $1.59 Million
Q2 2019

Aug 14, 2019
BUY
$67.77 - $82.2 $22,635 - $27,454
334 Added 1.71%
19,883 $1.63 Million
Q1 2019

May 15, 2019
BUY
$45.83 - $70.54 $90,926 - $139,951
1,984 Added 11.3%
19,549 $1.38 Million
Q4 2018

Feb 15, 2019
SELL
$41.17 - $56.44 $6,051 - $8,296
-147 Reduced 0.83%
17,565 $784,000
Q3 2018

Nov 20, 2018
SELL
$52.95 - $71.34 $8,683 - $11,699
-164 Reduced 0.92%
17,712 $998,000
Q2 2018

Aug 10, 2018
BUY
$56.38 - $68.08 $74,308 - $89,729
1,318 Added 7.96%
17,876 $1.2 Million
Q1 2018

May 17, 2018
BUY
$56.98 - $72.41 $23,760 - $30,194
417 Added 2.58%
16,558 $963,000
Q4 2017

Feb 13, 2018
BUY
$53.3 - $74.56 $860,315 - $1.2 Million
16,141
16,141 $1.04 Million

Others Institutions Holding ANIP

# of Institutions
211
Shares Held
19.2M
Call Options Held
3.4K
Put Options Held
10.8K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.08B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email